Innovation ActionsForthcomingHORIZON-CL6-2027-01-CIRCBIO-08

Biotechnology application for CCU

Horizon Europe

Per project€12M

1 phase

Deadline:2027-09-22

FundingLump Sum

💡

Strategic Analysis

This Innovation Action (IA) topic seeks to develop and demonstrate advanced biotechnologies for efficient carbon capture and utilisation (CCU), converting gaseous carbon into valuable non-food/feed/biofuel industrial feedstocks. A winning proposal must clearly articulate the scientific and technological breakthroughs in life sciences-based CCU, coupled with a robust business case, comprehensive sustainability assessment, and a clear path to market, including the feasibility of spin-off creation.

🚀

Suggested TRL Range

TRL 4 → 7

Based on programme defaults

Scope Activities (5)

SC2

develop and test innovative and effective life sciences-based technologies, either synthetic biology and/or living microorganisms, to concentrate, purify and convert gaseous carbon efficiently into suitable feedstock to produce products. Products in scope exclude food/feed and biofuels/syngas;

SC3

perform a preliminary assessment of the environmental impacts, the social and economic viability and business case of the developed technologies, including their scalability and the identification of markets for their output bio-based products;

SC4

demonstrate one or more technology(ies) among those developed and tested, with the highest environmental, economic and social sustainability;

SC5

evaluate and disseminate the replication potential of the demonstrated solution(s), including technical and economic/financial recommendations for SMEs and industrial operators in general;

SC6

assess the feasibility of establishing a spin-off to implement the results from the best technology(ies) demonstration.

Expected Outcomes (2)

EO1

innovative and improved purification and conversion of gaseous carbon is developed and scaled up to provide feedstock for industrial processes promoting circularity and climate neutrality;

EO2

advanced industries – applying life sciences technologies and biotechnology - contribute to the climate-neutrality objective.